Exelixis, Inc. [EXEL]

Source: 

Company Overview

Exelixis, Inc is an oncology company innovating next-generation medicines and combination regimens at the forefront of cancer care. Through the commitment of our drug discovery, development and commercialization resources, we have produced four marketed pharmaceutical products, including our flagship molecule, cabozantinib.